Travere Therapeutics, Inc. (TVTX) SEC filings

Name: Travere Therapeutics, Inc. (TVTX) SEC filings: latest 10-K, 10-Q, 8-K and insider forms
Creator: Agent Exchange
License: https://www.sec.gov/privacy#dissemination

CIK 0001438533 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in CA · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

	FY2025	FY2024	FY2022	FY2021
Revenue (USD)	490.7 M	109.5 M
Net income (USD)			-169.4 M	-146.4 M
Diluted EPS (USD/shares)	-0.29	-4.37

Latest filings

Filed	Form	Description	Period
2026-10-19	4	4	2026-10-15
2026-10-15	144	144
2026-09-21	8-K	8-K items 5.02,9.01	2026-09-21
2026-09-17	4	4	2026-09-15
2026-09-17	4	4	2026-09-15
2026-09-17	4	4	2026-09-15
2026-09-17	4	4	2026-09-15
2026-09-17	4	4	2026-09-15
2026-09-17	4	4	2026-09-15
2026-09-17	4	4	2026-09-15
2026-09-17	144	144
2026-09-17	144	144
2026-09-16	144	144
2026-09-16	144	144
2026-09-16	144	144
2026-09-15	144	144
2026-09-15	144	144
2026-09-15	144	144
2026-09-15	144	144
2026-09-15	144	144
2026-09-15	144	144
2026-09-15	144	144
2026-09-11	4	4	2026-09-10
2026-09-10	144	144
2026-09-03	4	4	2026-09-02

Forms on file (last 1,000): 4 446, 8-K 146, 144 131, SC 13G/A 72, 10-Q 33, SC 13G 23, SCHEDULE 13G/A 22, 424B5 16. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=TVTX (0.002 USD), /gw/filings/filings?ticker=TVTX&form=8-K, /gw/filings/facts?ticker=TVTX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange